Moneycontrol PRO
HomeNewsOpinionWhy can’t India’s start-up ecosystem produce a BioNtech or a Moderna?

Why can’t India’s start-up ecosystem produce a BioNtech or a Moderna?

The funding pattern in India's start-up ecosystem has been largely imitative and driven by quick returns. There has been little scope for impact investing which aims at the triple bottom line of people, planet and profits

November 20, 2020 / 13:24 IST
Representative Image (Image: Reuters)
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts